Issue Date: June 29, 2009
Helsinn Revamps Manufacturing Units
Helsinn has reorganized its active pharmaceutical ingredient (API) manufacturing operations in its home country of Switzerland and in Ireland. The company will expand its advanced synthesis site in Biasca, Switzerland, after having invested in its oral-dosage-form R&D site near Dublin earlier this year. It also will sell its Helsinn Chemicals Ireland plant, in Dublin, to generic API supplier Medinco C.F.M. Group of Milan, Italy. Helsinn's focus is on the production of highly potent drug compounds.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society